Multivariate analysis on factors affecting suppression of thyroid-stimulating hormone in treated congenital hypothyroidism

Hormone Research

Volumn 62, Issue 5, 2004, Pages 245-251

  Ng, S M ^a   Wong, S C ^a   Isherwood, D M ^a   Smith, C S ^a   Didi, M ^a  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Aetiology; Congenital hypothyroidism; Thyroid stimulating hormone

Indexed keywords

LEVOTHYROXINE; RADIOISOTOPE; THYROTROPIN; THYROXINE;

AGE DISTRIBUTION; ARTICLE; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; ENDOCRINE DISEASE; FEMALE; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; PATHOGENESIS; PATIENT CODING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; THYROID FUNCTION TEST; THYROID SCINTISCANNING; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

CHILD, PRESCHOOL; CONGENITAL HYPOTHYROIDISM; FEMALE; GREAT BRITAIN; HUMANS; HYPOTHYROIDISM; INFANT; INFANT, NEWBORN; MALE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; THYROTROPIN; THYROXINE;

EID: 9244222257     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081628     Document Type: Article

References (27)

1. American Academy of Pediatrics: Newborn screening for congenital hypothyroidism: Recommended guidelines. Pediatrics 1993; 91: 1203-1209.
2. Law WY, Bradley DM, Lazarus JH, John R, Gregory JW: Congenital hypothyroidism in Wales (1982-1993): Demographic features, clinical presentation and effects on early neurodevelopment. Clin Endocrinol 1998; 48: 201-207.
3. Hulse JA: Outcome for congenital hypothyroidism. Arch Dis Child 1984; 59: 23-30.
4. Grant DB: Growth in early treated congenital hypothyroidism. Arch Dis Child 1994; 70: 464-468.
5. Salerno M, Militerni R, Bravaccio B, Micillo M, Capalbo D, di Maio S, Tenore A: Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism. Thyroid 2002; 12: 45-52.
6. Heyerdahl S, Kase BF: Significance of elevated serum thyrotropin during treatment of congenital hypothyroidism. Acta Paediatr 1995; 84: 634-638.
7. Touati G, Leger J, Toublane JE, Farriaux JP, Stuckens C, Ponte C, David M, Rocchicoli P, Porquet D, Czernichow P: A thyroxine dosage of 8 mcg/kg/day is appropriate for initial treatment of the majority of infants with congenital hypothyroidism. Eur J Pediatr 1997; 156: 94-98.
8. Abusrewil SSA, Tyfield L, Savage DCL: Serum thyroxine and thyroid stimulating hormone concentrations after treatment of congenital hypothyroidism. Arch Dis Child 1988; 63: 1368-1371.
9. Grant DB, Fuggle PW, Smith I: Increased plasma thyroid stimulating hormone in treated congenital hypothyroidism: Relation to severity of hypothyroidism, plasma thyroid hormone status and daily dose of thyroxine. Arch Dis Child 1993; 69: 555-558.
10. Redmond GP, Soyka LF: Abnormal TSH secretory dynamics in congenital hypothyroidism. J Pediatr 1981; 98: 83-85.
11. Brown J, Datta V, Sutton AJ, Swift PGF: Suppression of TSH in congenital hypothyroidism is significantly related to serum levels and dosage of thyroxine. Horm Res 2003; 59: 85-90.
12. Grant DB: Monitoring TSH concentrations during treatment for congenital hypothyroidism. Arch Dis Child 1991; 66: 669-671.
13. Eldar D, Kaiserman I, Sack J: Early identification of congenital hypothyroid infants with abnormalities in pituitary setpoint for T4-induced TSH release. Horm Res 1993; 40: 194-200.
14. Muir A, Daneman D, Daneman A, Ehrlich R: Thyroid scanning, ultrasound and serum thyroglobulin in determining the origin of congenital hypothyroidism. Am J Dis Child 1988; 142: 214-216.
15. Sfakianakis GN, Ezuddin SH, Sanchez JE, Eidson M, Cleveland W: Pertechnetate scintigraphy in primary congenital hypothyroidism. J Nucl Med 1999; 40: 799-804.
16. Germak JA, Foley TP: Longitudinal assessment of L-thyroxine therapy for congenital hypothyroidism. J Pediatr 1990; 2: 211-219.
17. Hanakoglu A, Perlman K, Shamis I, Brnjac L, Rovet J, Daneman D: Relationship of etiology to treatment in congenital hypothyroidism. J Clin Endocrinol Metab 2002; 86: 186-191.
18. Ng SM, Wong SC, Didi M: Head circumference and linear growth during the first 3 years in treated congenital hypothyroidism in relation to aetiology and initial biochemical severity. Clin Endocrinol 2003; 61: 155-159.
19. Raza J, Hindmarsh PC, Brook CGD: Factors involved in the rate of fall of thyroid-stimulating hormone in treated hypothyroidism. Arch Dis Child 1997; 77: 526-527.
20. Hulse JA, Grant DB, Jackson D, Clayton BE: Growth, development and reassessment of hypothyroid infants diagnosed by screening. BMJ 1982; 284: 1435-1437.
21. Chiovato L, Giusti L, Tonacchera M: Evaluation of L-thyroxine replacement therapy in children with congenital hypothyroidism. J Endocrinol Invest 1991; 14: 957-964.
22. LaFranchi S: Congenital hypothyroidism: Etiologies, diagnosis and management. Thyroid 1999; 9: 735-740.
23. Song S, Daneman D, Rovet J: Influence of aetiology and treatment factors on intellectual outcome in congenital hypothyroidism. J Dev Behav Pediatr 2001; 22: 376-384.
24. Rovet JF, Ehrlich RM: Long term effects of L-thyroxine therapy for congenital hypothyroidism. J Pediatr 1995; 126: 380-386.
25. Selva KA, Mandel SH, Rien L, Sesser D, Miyahira R, Skeels M, Nelson JC, LaFranchi SH: Initial treatment dose of L-thyroxine in congenital hypothyroidism. J Pediatr 2002; 141: 786-792.
26. Schultz RM, Glassman MS, Macgillivary MH: Elevated threshold for thyrotropin suppression in congenital hypothyroidism. Am J Dis Child 1980; 134: 19-20.
27. Working group on neonatal screening of the European Society of Paediatric Endocrinology: Revised guidelines for neonatal screening programmes for primary congenital hypothyroidism. Horm Res 1999; 52: 49-52.